FDA & Devices: Boston Scientific is pulling its Imager II angiographic catheters after a manufacturing defect that can cause the tip to degrade or detach, raising the risk of procedure delays and potentially life-threatening embolism. FDA Approvals: The agency cleared updated COVID-19 vaccines for the 2026–2027 season and approved new treatments including Lisraya for adults with dermatomyositis, Bixlenvo for virologically suppressed adults with HIV, and Priovant’s Lisraya plus other cardiometabolic updates. AI in Care: A new focus on “AI scribes” highlights growing physician use alongside patient-satisfaction questions and safety risks like hallucinations and omissions; separate debate in JAMA argues AI may outperform doctors on core cognitive tasks by 2030. Health Equity & Access: South Texas House races spotlight rising healthcare costs after ACA coverage drops; another report flags a “public health crisis” tied to skipping care until it’s more expensive. Public Health & Safety: Brown’s Pandemic Center tracks outbreaks and pushes guidance to prevent and mitigate infectious disease emergencies. Policy & Courts: A Fifth Circuit ruling limits OSHA’s mental illness recordkeeping authority, while abortion litigation in South Carolina moves to a bench trial over whether the six-week ban is unconstitutionally vague. Care Delivery Innovation: Tampa General and Florida Orthopaedic Institute performed the first-ever surgery using the EVOS pelvic/acetabular system for complex trauma.